CVS Health Corp. on Wednesday reported a hefty loss in its third quarter on charges, despite higher revenues. Adjusted earnings and revenues topped market estimates. Further, the health insurer trimmed its fiscal 2022 outlook for reported earnings, but raised adjusted earnings view in line or above analysts' estimates.
In pre-market activity on the NYSE, CVS shares were gaining around 1 percent to trade at $95.49.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com